An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye

An Eight-Week, Double-Masked, Randomized, Placebo-Controlled, Phase 2, Evaluation of the Safety and Efficacy of VSJ-110 Ophthalmic Solution in the Treatment of Dry Eye

The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.

Inclusion Criteria:

• Be at least 18 years of age of either gender and any race.
• Provide written informed consent and sign the HIPAA form.
• Be willing and able to follow all instructions and attend all study visits.

Exclusion Criteria:

• Use of any of the disallowed medications during the washout and study period.